A Computer-based Pharmacokinetic Implementation for Digoxin Therapeutic Monitoring in Pediatric Patients
نویسندگان
چکیده
ABTRACT Because of the narrow therapeutic range and large inter-patient variability in digoxin’s pharmacokinetics and pharmacodynamics, an appropriate dosage regimen for individuals is needed. However, monitoring and adjusting the optimal individualized dosage regimen requires a knowledge and familiarity of pharmacokinetic equations. The objective of this study was to develop a computer-based pharmacokinetic implementation for individualized digoxin pharmacokinetic parameters, dosage regimen, and predicted concentrations in pediatric patients. The program was developed using Microsoft Access 2000. Validated digoxin pharmacokinetic parameters for pediatrics from a previous study were used to test the computer-based pharmacokinetic program. After entering a patient’s data, the program calculated the pharmacokinetic parameters and a dosage regimen for each patient to achieve the therapeutic goals; the predicted concentrations at non-steady state and steady state from selected doses were also calculated. For program testing, 30 pediatric patients from the validation group were used to calculate pharmacokinetic parameters. The mean prediction error (bias) was -0.111 ng/mL (95% CI: -0.218 to 0.004) and precision (RMSE) was 0.315 ng/mL (95% CI: 0.237 to 0.378). Compared to manual calculations, using the computer program required less than one fifth of the time. This simple computer program was developed to assist the pharmacist and healthcare team in terms of accuracy, timesaving, and convenience for digoxin pharmacokinetic calculation and therapeutic monitoring in pediatric patients.
منابع مشابه
Therapeutic Drug Monitoring and Population Pharmacokinetics of Digoxin in Jordanian Patients
Therapeutic monitoring of digoxin and the population pharmacokinetic parameters in Jordanian patients were done. Fifty three patients visited cardiac department of Jordan University hospital participated in this study, thirty two patients had congestive heart failure (CHF), while twenty one patients had atrial fibrillation (AF). Ninety three blood samples were collected from those patients for ...
متن کاملInspection of Digoxin level in cardiac heart failure patients refer to Taemin Ejtemai and Shohadaye Ashaer clinic
Background: Heart failure is one of the common cardiovascular diseases and digoxin has the positive effect on it. But unfortunately in spite of its positive effect on heart failure therapeutic and toxic level of it in patients is different and close to each other. The aim of this research was determination of digoxin serum level in failur heart patients. Materials and methods: In this cros...
متن کاملDigoxin and Digitoxin Convert Atrial Fibrillation and Flutter to Regular Sinus Rhythm with Pharmacokinetically Optimized Dosage Regimens
Background Does digitalis convert atrial fibrillation or flutter (AF) to regular sinus rhythm (RSR)? In several studies digoxin was no better than placebo. Therapeutic serum digoxin concentrations are 0.5 to 2.0 ng/ml. However, sensitivity to digoxin varies widely, rate control in AF is often not achieved until 2 ng/ml, and many patients tolerate much higher concentrations. Methods Pharmacokine...
متن کاملA Review on Therapeutic Drug Monitoring of Immunosuppressant Drugs
Immunosuppressants require therapeutic drug monitoring because of their narrow therapeutic index and significant inter-individual variability in blood concentrations. This variability can be because of factors like drug-nutrient interactions, drug-disease interactions, renal-insufficiency, inflammation and infection, gender, age, polymorphism and liver mass. Drug monitoring is widely practiced ...
متن کاملElectrocardiographic manifestation of digoxin toxicity in a Pomeranian dog
This case report describes several electrocardiographic findings in an 8-years old female Pomeranian dog that was referred with a history of digoxin overdose. Electrocardiographic abnormalities detected in this case could be classified as primary electrocardiographic disturbances, reflecting cardiac chamber enlargement and secondary ECG changes, attributed to digoxin toxicity. ECG manifestatio...
متن کامل